Cannabis & Alternatives — FDA Fast-Tracks Three Psychedelic Drugs; Missouri Signs Hemp Regulation Law; Tennessee Sends Mixed Signals on Cannabis Reform

Cannabis & Alternatives · 2026-04-28

TODAY'S SIGNAL — The regulatory landscape is shifting on multiple fronts simultaneously. The FDA's decision to grant priority review vouchers to three psychedelic drugs — two psilocybin-based for depression and one methylone-based — represents the most consequential federal signal for the alternatives sector in months, accelerating timelines for what could become the first FDA-approved…